2 X j9 O, H( C h1 D& U2 I3 PDYAX下周三(Dec 1,09)的fda,从周一开始应该有一波涨势。 可趁机短炒。如果愿意, 可以赌一下fda,如通过股价可上$5, 但毕竟风险极大。' |/ P9 \; u+ w8 G6 n
5 C1 M; W i1 C& Q9 f
DYAX的DX88作为治疗遗传性血管水肿(HAE)的药物在美国和欧洲都获得孤儿药的资格。HAE是一种罕见、可致命的常染色体显性遗传性疾病,全世界1,0000到5,0000人中即有一人患有HAE。# S" A0 E! z0 H! F- D8 g
. n! l/ Q: v6 V* g
推荐股票,不具备任何投资依据。风险自负。
DX-88 has been approved by FDA today, stocks will be soared to a new high tomorrow, wait and see how much it will go. It seems there are small base of HAE patients. Thanks for Jason1231.